3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
22
Squamous Cell Carcinoma of Head and Neck
16
Colonic Neoplasms
11
Rectal Neoplasms
8
Head and Neck Neoplasms
7
Neoplasm Metastasis
5
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Pancreatic Neoplasms
3
Ovarian Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Chordoma
2
Breast Neoplasms
2
Unresectable Colorectal Cancer
1
Tongue Neoplasms
1
Thymoma
1
Solid Tumor, Adult
1
Solid Cancer
1
Skin Neoplasms
1
Rectal Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oropharyngeal Neoplasms
1
Noonan Syndrome
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Metastatic Colorectal Adenocarcinoma
1
Lymphoid Interstitial Pneumonia
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Interventions
pembrolizumab
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Noonan Syndrome
×
Cetuximab
×
Clear all
NCT04670679
2026-03-25
FLAGSHP-1
Erasca, Inc.
Phase 1
Active not recruiting
90 enrolled